Avitus Orthopaedics

Avitus Orthopaedics is a medical device company specializing in minimally invasive surgical technologies. It focuses on developing innovative solutions to enhance surgical procedures, particularly in orthopaedics and podiatry. Founded in 2011 and headquartered in Farmington, US, Avitus Orthopaedics is a developer of advanced medical devices. The company was established by founders Maxim Budyansky and Selman Soydaş.

It has undergone strategic developments since its inception and has raised USD 0. 35 mn in venture funding as of December 2015, with a total amount of USD 0. 35 mn raised across two deals. Avitus Orthopaedics specializes in the development of innovative medical devices focused on minimally invasive surgery.

The company's flagship product, the Avitus® Bone Harvester, utilizes advanced suction curettage technology to efficiently harvest autologous bone and bone marrow. This device allows surgeons to obtain up to 50cc of cancellous bone and additional non-diluted bone marrow through a small incision, catering to applications such as grafting, joint revisions, and treatment of conditions like osteomyelitis and bone tumors. Complementing the Avitus® Bone Harvester are the ArchiMIS™ and DragonWing™ systems, which facilitate percutaneous autogenous graft delivery, serving healthcare professionals primarily in orthopaedics and podiatry markets across the United States, Europe, and Asia. Avitus Orthopaedics generates revenue through direct sales of its medical devices to healthcare facilities, including hospitals and surgical centers.

The Avitus® Bone Harvester is marketed via a B2B model, where transactions occur between Avitus and healthcare providers utilizing its technologies in surgical procedures. Additional revenue is supported by educational events and partnerships with medical professionals to enhance the practical application of their products, with pricing determined by the specific needs of each provider and procedure complexity. Avitus Orthopaedics is focused on future growth through the development of new products aimed at enhancing surgical techniques and expanding its market reach. The company aims to enter new geographic regions, specifically targeting markets in Europe and Asia by 2025.

The recent funding of USD 0. 35 mn raised in December 2015 will support these initiatives, facilitating product development and market entry efforts.